Editorial: Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of Risk
- PMID: 35345484
- PMCID: PMC8957109
- DOI: 10.3389/fcvm.2022.849882
Editorial: Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of Risk
Keywords: cardiac computed tomographic (CT) imaging; cardiac magnetic resonance (CMR); cardiomyopathies; genetics; histology; imaging; risk; strain.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of Risk
References
-
- Authors/Task Force, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. . 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. (2014) 35:2733–79. 10.1093/eurheartj/ehu284 - DOI - PubMed
-
- Writing Committee M, Ommen SR, Mital S, Burke MA, Day SM, Deswal A, et al. . 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. (2020) 142:e533–e557. 10.1161/CIR.0000000000000938 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources